Pseudotyped Virus for Papillomavirus

Adv Exp Med Biol. 2023:1407:85-103. doi: 10.1007/978-981-99-0113-5_5.

Abstract

Papillomavirus is difficult to culture in vitro, which limits its related research. The development of pseudotyped virus technology provides a valuable research tool for virus infectivity research, vaccine evaluation, infection inhibitor evaluation, and so on. Depending on the application fields, different measures have been developed to generate various kinds of pseudotyped papillomavirus. L1-based and L2-based HPV vaccines should be evaluated using different pseudotyped virus system. Pseudotyped papillomavirus animal models need high-titer pseudotyped virus and unique handling procedure to generate robust results. This paper reviewed the development, optimization, standardization, and application of various pseudotyped papillomavirus methods.

Keywords: Cervical cancer; Human papillomavirus; Neutralization; Pseudotyped virus.

MeSH terms

  • Animals
  • Antibodies, Viral
  • Capsid Proteins / genetics
  • Oncogene Proteins, Viral* / genetics
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines* / genetics
  • Papillomavirus Vaccines* / therapeutic use
  • Viral Pseudotyping

Substances

  • Capsid Proteins
  • Oncogene Proteins, Viral
  • Papillomavirus Vaccines
  • Antibodies, Viral